BENZTROPINE

Course overview

BENZTROPINE IS FDA-APPROVED AS ADJUNCTIVE THERAPY FOR ALL FORMS OF PARKINSONISM. IT IS ALSO USED FOR DRUG-INDUCED EXTRAPYRAMIDAL SYMPTOMS, PREVENTION OF DYSTONIC REACTIONS, AND TREATMENT OF ACUTE DYSTONIC REACTIONS. THIS ACTIVITY EXAMINES THE INDICATIONS, MECHANISM OF ACTION, DOSING, ADVERSE EVENT PROFILE, AND OTHER FACTORS SO MEMBERS OF THE INTERPROFESSIONAL HEALTHCARE TEAM CAN MAKE INFORMED DECISIONS REGARDING THE USE OF BENZTROPINE.